German health data reveals how rare heart condition affects patients
NCT ID NCT07494656
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses anonymous health insurance records from Germany to learn more about a rare heart condition called ATTR-CM, where abnormal protein builds up in the heart. Researchers will look at survival rates, hospital visits, and how common the disease is. No new treatments are being tested—this is about understanding the disease better from real-world data.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTR-CM (TRANSTHYRETIN AMYLOID CARDIOMYOPATHY) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pfizer
Berlin, 10117, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.